Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study
Compose a Response to This Article
Other responses
No responses have been published for this article.
